Perfil de seguridad El perfil de seguridad de Retatrutida documentado en estudios clnicos publicados (Jastreboff 2023, Rosenstock 2023) se concentra en eventos gastrointestinales mediados por agonismo GLP-1 central: Eventos gastrointestinales (frecuencia alta): nusea, vmito, diarrea y estreimiento, dosis-dependientes y mayoritariamente leves a moderados, con incidencia mxima durante las primeras semanas de titulacin
Why are these patients most at risk
At baseline, 57% of the population had diabetes mellitus more than 5 years and had a mean hemoglobin A1c (HbA1c) of 8%
Phase 3: Continued escalation (weeks 9 through 12) Dose: 1.0 mg once weekly At 1 mg, the appetite effects become pronounced for most people
Every pound of body weight translates to roughly four pounds of force on your knee joints during normal walking
Our safe, personalized care ensures natural results